Truist Securities Downgrades Amrize to Hold, Lowers Price Target to $48

Amrize Ltd

Amrize Ltd

AMRZ

0.00

Truist Securities analyst Keith Hughes downgrades Amrize (NYSE: AMRZ) from Buy to Hold and lowers the price target from $65 to $48.